HopeStage
Back to overview

Bipolarity studies

Topics
More filters

Bipolarity

Bipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.

1979studies shown
Showing 457-468 of 1,979
Drug study icon
CompletedNCT00271258

Safety Study of Sodium Divalproate in Bipolarity in Adolescents

Official study title

STUDY OF THE TOLERANCE OF SODIUM DIVALPROATE (DEPAKOTE) IN ADOLESCENTS IN MANIC, MIXED OR HYPOMANIC EPISODES OF BIPOLAR DISORDER

This study has finished and is no longer accepting participants.

In Paris
BipolarityMedication studyAges 13–18
Countries
France
Sponsor
Sanofi
Behavioral study icon
CompletedNCT00993850

Sleep Disturbance and Bipolarity

Official study title

A Psychological Intervention for Individuals Who Suffer From Sleep Disturbance and Bipolar Disorder

This study has finished and is no longer accepting participants.

In Berkeley
BipolarityBehavioural studyAges 18+
Countries
United States
Sponsor
University of California, Berkeley
Drug study icon
CompletedNCT00036348

Aripiprazole in people with a History of Bipolarity

Official study title

Study of Aripiprazole in Patients With a History of Bipolar Disorder

This study has finished and is no longer accepting participants.

Multiple locations, including Birmingham
BipolarityMedication studyAges 18+
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Drug study icon
CompletedNCT00036101

Aripiprazole in the Treatment of people with Acute Symptoms in Bipolarity

Official study title

Study of Aripiprazole in the Treatment of Patients With Acute Symptoms in Bipolar Disorder

This study has finished and is no longer accepting participants.

Multiple locations, including Tuscaloosa
BipolarityMedication studyAges 18+
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Drug study icon
CompletedNCT00046384

Aripiprazole in the Treatment of people with Acute Symptoms of Bipolarity

Official study title

Study of Aripiprazole in the Treatment of Patients With Acute Symptoms of Bipolar Disorder

This study has finished and is no longer accepting participants.

Multiple locations, including Scottsdale
BipolarityMedication studyAges 18+
Countries
United States, Argentina
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Drug study icon
TerminatedNCT00665444

Aripiprazole to Reduce Medical Risks in Bipolarity

Official study title

Reducing Medical Risks in Individuals With Bipolar Disorder: Enhancing Outcomes With Aripiprazole

This study ended early.

In Pittsburgh
BipolarityMedication studyAges 18–65
Countries
United States
Sponsor
University of Pittsburgh
Drug study icon
CompletedNCT02731612

the Efficacy of Lurasidone in Cognitive Functioning in Bipolar Patients

What is this study about?

This study evaluated the effectiveness of lurasidone for people with bipolarity.

This study has finished and is no longer accepting participants.

Multiple locations, including Boston
BipolarityMedication studyAges 19–65
Countries
United States, Canada, United Kingdom, + 1 other
Sponsor
Lakshmi N Yatham
Drug study icon
CompletedNCT00012558

Systematic Treatment Enhancement Program for Bipolarity (STEP-BD)

Official study title

Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)

This study has finished and is no longer accepting participants.

Multiple locations, including Stanford
BipolarityMedication studyAges 15+
Countries
United States
Sponsor
National Institute of Mental Health (NIMH) (Government agency)

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.